1. Home
  2. GH vs STZ Comparison

GH vs STZ Comparison

Compare GH & STZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardant Health Inc.

GH

Guardant Health Inc.

N/A

Current Price

$150.81

Market Cap

22.9B

Sector

Health Care

ML Signal

N/A

Logo Constellation Brands Inc.

STZ

Constellation Brands Inc.

N/A

Current Price

$141.94

Market Cap

19.5B

ML Signal

N/A

Company Overview

Basic Information
Metric
GH
STZ
Founded
2011
1945
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
22.9B
19.5B
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
GH
STZ
Price
$150.81
$141.94
Analyst Decision
Strong Buy
Buy
Analyst Count
26
24
Target Price
★ $202.24
$152.91
AVG Volume (30 Days)
1.7M
★ 2.1M
Earning Date
11-05-2026
10-06-2026
Dividend Yield
N/A
★ 2.85%
EPS Growth
★ 6.74
N/A
EPS
N/A
★ N/A
Revenue
$982,021,000.00
★ $9,139,000,000.00
Revenue This Year
$38.41
N/A
Revenue Next Year
$35.18
$1.50
P/E Ratio
★ N/A
$24.93
Revenue Growth
★ 32.88
N/A
52 Week Low
$74.55
$110.60
52 Week High
$191.05
$168.60

Technical Indicators

Market Signals
Indicator
GH
STZ
Relative Strength Index (RSI) 34.54 64.64
Support Level $140.86 $137.61
Resistance Level $177.55 $152.34
Average True Range (ATR) 9.94 3.70
MACD -2.28 0.97
Stochastic Oscillator 20.79 65.27

Price Performance

Historical Comparison
GH
STZ

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About STZ Constellation Brands Inc.

Constellation Brands is the largest provider of alcoholic beverages across the beer, wine, and spirits categories in the US, generating more than 90% of revenue from Mexican beer imports under top-selling brands such as Modelo and Corona. The rest of the business includes some remaining wine and spirits brands, categories where the company has pruned assets in recent years. With its exclusive rights tied to the Mexican beer brands effective only in the US, the firm has limited revenue exposure to international markets. Constellation owns a 10% stake in Canopy Growth, a medicinal and recreational cannabis producer in Canada, and has a 50/50 joint venture with glass manufacturer Owens-Illinois in Mexico.

Share on Social Networks: